You are here: Home » News-CM » Companies » Results
Business Standard

Glenmark Pharmaceuticals consolidated net profit declines 53.08% in the June 2019 quarter

Capital Market 

Sales rise 7.24% to Rs 2283.60 crore

Net profit of Glenmark Pharmaceuticals declined 53.08% to Rs 109.31 crore in the quarter ended June 2019 as against Rs 232.99 crore during the previous quarter ended June 2018. Sales rose 7.24% to Rs 2283.60 crore in the quarter ended June 2019 as against Rs 2129.37 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales2283.602129.37 7 OPM %14.9716.29 -PBDT250.57406.09 -38 PBT159.84326.70 -51 NP109.31232.99 -53

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, August 14 2019. 10:48 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU